Mechanisms of arsenic carcinogenicity: Genetic or epigenetic mechanisms?

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 19, Issue 3, 2000, Pages 281-286

  Simeonova, P P ^a   Luster, M I ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Bladder cancer; Gene expression; Reactive oxygen species; Skin cancer

Indexed keywords

ARSENIC;

ARTICLE; BLADDER CANCER; CANCER RISK; CARCINOGENICITY; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; SKIN CANCER;

ANIMALS; ARSENIC; CARCINOGENS; HUMANS; LUNG NEOPLASMS; NEOPLASMS; SKIN NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0033863047     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ingested arsenic and internal cancer: A historical cohort study followed for 33 years
2. Cancer risks from arsenic in drinking water
3. Incidence of internal cancers and ingested inorganic arsenic: A 7-year follow-up study in Taiwan
4. Arsenic in dermatology
5. The inhibitory effect of UVB irradiation on the expression of p53 and Ki-67 proteins in arsenic-induced Bowen's disease
6. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers
7. Cancers related to exposure to arsenic at a copper smelter
8. Arsenic and arsenic compounds. IARC monograph on the evaluation of carcinogenic risks to humans: Overall evaluations of carcinogenicity
9. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population
10. Absence of arsenite mutagenicity in E. coli and Chinese hamster cells
11. The reproductive effects assessment group's report on mutagenicity of inorganic arsenic
12. Induction by inorganic metal salts of sister chromatid exchanges and chromosome aberrations in human and Syrian hamster cell strains
13. Sister chromatid exchanges in human peripheral blood lymphocytes after ingestion of high doses of arsenicals
14. Induction of gene amplification by arsenic
15. Inhibition of DNA ligase activity by arsenite: A possible mechanism of its comutagenesis
16. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression
17. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: A model for a mechanism of carcinogenesis
18. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase
19. Dermatotoxic chemical stimulate of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes
20. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro
21. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors
22. Effects of acute and chronic arsenic exposure of human-derived kertinocytes in an in vitro human skin equivalent system: A novel model of human arsenicism
23. Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: Relevance to arsenic carcinogenesis
24. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with AP-1 transactivation
25. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation
26. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder
27. p53 and c-jun expression in urinary bladder transitional cell carcinoma: Correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage
28. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats
29. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats
30. Effects of dietary dimethylarsinic acid on the urine and urothelium of rats
31. Reactions of arsenic(III) and arsenic(V) species with glutathione
32. Autoradiographic studies on the distribution of arsenic in mice and hamster administered 74As-arsenite or -arsenate
33. Concentration and chemical species of arsenic in human tissue
34. Metal carcinogenesis: Mechanistic implications
35. Redox regulation of NF-κB activation
36. Induction of the mammalian stress response gene GADD 153 by oxidative stress: Role of AP-1 element
37. Transfer of arsenite from glutathione to dithiols: A model of interaction
38. The role of oxidative DNA damage in human arsenic carcinogenesis: Detection of 8-hydroxy-2-deoxyguanosine in arsenic-related Bowen's diseases
39. Differential activation of ERK, JNK/SAPK, and P38/CSBP/RK map kinase family members during the cellular response to arsenite
40. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and shc
41. Requirement of ERK, but not JNK, for arsenite-induced cell transformation
42. Structurally based, selective interaction of arsenite with steroid receptors
43. Mitogen-activated protein kinase cascades and regulation of gene expression
44. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast
45. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers
46. Detection of transforming growth factor α in normal malignant and hyperproliferative human keratinocytes
47. Overexpression of TGF alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
48. Cancer induction by an organic arsenic compound, dimethylarsinic acid (Cacodylic Acid), in F344/ DuCrj rats after pretreatment with five carcinogens
49. Transcription factor EGR-1 regulates glomerular mesangial cell proliferation
50. Expression of early growth response genes in human prostate cancer